Literature DB >> 18408621

Ventilatory efficiency and resting hemodynamics in hypertrophic cardiomyopathy.

Ross Arena1, David S Owens, Josefino Arevalo, Kevin Smith, Saidi A Mohiddin, Dorothea McAreavey, Karen L Ulisney, Dorothy Tripodi, Lameh Fananapazir, Jonathan F Plehn.   

Abstract

PURPOSE: In patients with systolic heart failure, the ability of cardiopulmonary exercise testing (CPX) variables to reflect pathophysiology is well established. The relationship between CPX and pathophysiology has, however, not been thoroughly investigated in patients with nonobstructive hypertrophic cardiomyopathy (NHCM). The objective of this study was to assess the ability of CPX variables to reflect resting hemodynamics in patients with nonobstructive hypertrophic cardiomyopathy NHCM.
METHODS: We performed CPX and right heart catheterization on 83 subjects with NHCM (51 male/32 female, mean age = 38 +/- 10 yr, NYHA I-III mean = 1.7). Peak oxygen consumption ( O2) and minute ventilation/carbon dioxide ratio (V E/VCO2) at peak exercise were compared to resting hemodynamics including pulmonary artery systolic, diastolic and mean pressures (PASP, PADP and MPAP), and pulmonary capillary wedge pressure (PCWP).
RESULTS: Elevations in PCWP (> or = 15 mm Hg), PASP (> or =30 and > or = 40 mm Hg), PADP (> 15 mm Hg) and MPAP (> or = 20 mm Hg) were detected in 22, 33, 10, and 23% of subjects, respectively. Peak V E/VCO2 (positive correlation) and peak VO2 (negative correlation) correlated modestly with all pressure measurements (r = 0.33-0.51, P < 0.01 for all measurements). By receiver operating curve analysis, a V E/VCO2 >35.5 exhibited the best diagnostic accuracy with a curve areas of 0.81 for PAP > or = 30 mm Hg (sensitivity/specificity = 86%/67%), 0.87 for PAP > or = 40 mm Hg (77%/100%), 0.86 for MPAP > 20 mm Hg (83%/79%), and 0.84 for PCWP > or = 15 mm Hg (80%/76%).
CONCLUSIONS: CPX can accurately identify abnormal resting hemodynamics in patients with NHCM. Further testing of this modality in other forms of diastolic dysfunction may be warranted.

Entities:  

Mesh:

Year:  2008        PMID: 18408621     DOI: 10.1249/MSS.0b013e31816459a1

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  10 in total

Review 1.  Cardiopulmonary exercise testing in the assessment of pulmonary hypertension.

Authors:  Ross Arena; Marco Guazzi; Jonathan Myers; Daniel Grinnen; Daniel E Forman; Carl J Lavie
Journal:  Expert Rev Respir Med       Date:  2011-04       Impact factor: 3.772

2.  Determinants of peak oxygen uptake in patients with hypertrophic cardiomyopathy: a single-center study.

Authors:  Damiano Magrì; Piergiuseppe Agostoni; Filippo Maria Cauti; Beatrice Musumeci; Gabriele Egidy Assenza; Carlo Nicola De Cecco; Giuseppe Muscogiuri; Antonello Maruotti; Agnese Ricotta; Erika Pagannone; Laura Marino; Daria Santini; Giulia Proietti; Andrea Serdoz; Francesco Paneni; Massimo Volpe; Camillo Autore
Journal:  Intern Emerg Med       Date:  2012-10-07       Impact factor: 3.397

3.  Diastolic dysfunction is associated with exercise impairment in patients with sickle cell anemia.

Authors:  Tarek Alsaied; Omar Niss; Adam W Powell; Robert J Fleck; James F Cnota; Clifford Chin; Punam Malik; Charles T Quinn; Michael D Taylor
Journal:  Pediatr Blood Cancer       Date:  2018-05-21       Impact factor: 3.167

4.  Correlation of Hemodynamic and Respiratory Parameters in Invasive Cardiopulmonary Exercise Testing (iCPET).

Authors:  Dirk Habedank; Anne Obst; Alexander Heine; Beate Stubbe; Ralf Ewert
Journal:  Life (Basel)       Date:  2022-04-28

5.  EACPR/AHA Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations.

Authors:  Marco Guazzi; Volker Adams; Viviane Conraads; Martin Halle; Alessandro Mezzani; Luc Vanhees; Ross Arena; Gerald F Fletcher; Daniel E Forman; Dalane W Kitzman; Carl J Lavie; Jonathan Myers
Journal:  Circulation       Date:  2012-09-05       Impact factor: 29.690

6.  Exercise intolerance in pulmonary arterial hypertension.

Authors:  Robin M Fowler; Kevin R Gain; Eli Gabbay
Journal:  Pulm Med       Date:  2012-06-10

7.  Pulmonary congestion at rest and abnormal ventilation during exercise in chronic systolic heart failure.

Authors:  Gabriella Malfatto; Sergio Caravita; Alessia Giglio; Jessica Rossi; Giovanni B Perego; Mario Facchini; Gianfranco Parati
Journal:  J Am Heart Assoc       Date:  2015-05-05       Impact factor: 5.501

8.  Effect of pre-discharge cardiopulmonary fitness on outcomes in patients with ST-elevation myocardial infarction after percutaneous coronary intervention.

Authors:  He Cai; Yang Zheng; Zhaoxi Liu; Xinying Zhang; Rongyu Li; Wangshu Shao; Lin Wang; Lin Zou; Pengyu Cao
Journal:  BMC Cardiovasc Disord       Date:  2019-09-06       Impact factor: 2.298

9.  Cardiopulmonary Exercise Testing as a Tool for Diagnosing Pulmonary Hypertension in Patients with Dilated Cardiomyopathy.

Authors:  Akihiro Hirashiki; Takahisa Kondo; Takahiro Okumura; Yoshihiro Kamimura; Yoshihisa Nakano; Kenji Fukaya; Akinori Sawamura; Ryota Morimoto; Shiro Adachi; Kyosuke Takeshita; Toyoaki Murohara
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-02-01       Impact factor: 1.468

10.  Insights from Cardiopulmonary Exercise Testing in Pediatric Patients with Hypertrophic Cardiomyopathy.

Authors:  Giovanna Gallo; Vittoria Mastromarino; Giuseppe Limongelli; Giulio Calcagni; Antonello Maruotti; Luca Ragni; Fabio Valente; Maria Beatrice Musumeci; Rachele Adorisio; Marta Rubino; Camillo Autore; Damiano Magrì
Journal:  Biomolecules       Date:  2021-03-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.